drugset / Trial / NCT02648659
The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Non-randomizedParallel-groupSingle-blindTreatment
Summary
This study assessed the effect of tailored eradication therapy according to Clarithromycin resistance in Helicobacter pylori patients.
Timeline
- Start
- 2016-03-02
- Primary completion
- 2017-01-06
- Completion
- 2017-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Ilaprazole | Small molecule | 10 mg | — |
| Subject | Metronidazole | Small molecule | 500 mg | — |
| Background | Amoxicillin | Other / unclassified | 500 mg | — |